[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$mgtx](/topic/$mgtx)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mgtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mgtx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% +17%  
**1 Month**: XXX% no change  
**6 Months**: XXX% no change  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-10-11  

**Most Supportive Themes**
- **Parkinson's Breakthrough:** (40%) Positive news regarding a British-led gene therapy for Parkinson's disease is being hailed as a 'game changer'. This is supported by high engagement on related posts.
- **Analyst Ratings and Target Prices:** (20%) Positive analyst ratings and target prices for MeiraGTx ($MGTX) are present, indicating potential for growth. This is supported by mentions of analyst ratings.
- **Category Overview:** (15%) Mentions in the context of broader market overviews, particularly in Bio/Pharm, suggest a positive outlook. This is supported by the inclusion of $MGTX in lists of promising stocks.
  
**Most Critical Themes**
- **Overall Engagement Down:** (25%)  Despite a surge in mentions, overall engagement is down. This is a critical factor to consider.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %    |
| ------- | -------- | -   | ------- | -   | -------- | -    |
| X       | X        | XX% | X       | XX% |          |      |
|         |          |     |         |     |          |      |
| Total   | X        | XX% | X       | XX% | X        | NaN% |